Thyroid Hormone Receptor Antagonist (1-850) Catalog No.:M22803-C and 62% of the radioactivity

and 62% of the radioactivity

B I09 is highly effective in inhibiting splicing of XBP1 mRNA in human WaC3 cells and the expression of XBP-1s in LPS stimulated B cells

[2H]C([2H])([2H])C([2H])([2H])[C@]1(O)C2C=C3C4=NC5=CC(F)=C(C)C6CC[C@H](NC(=O)CN)C(C=65)=C4CN3C(=O)C=2COC1=O

The retention or efflux of phthalanilide (NSC 60339)-lipid complexes by sensitive or resistant murine tumor cells and Escherichia coli B

Pomalidomide-amino-PEG5-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and a linker used in PROTAC technology

Thyroid Hormone Receptor Antagonist (1-850) Catalog No.:M22803-C and 62% of the radioactivityTarget: thyroid hormone receptor IC50: 1. 5 M Thyroid hormone receptor antagonist (1 850) was screened from a library of more than 250000 compounds as the antagonist of thyroid hormone receptor with the highest affinity. Thyroid Hormone Receptor Antagonist, 1 850 is a cell permeable hydrazinyl carboxamide compound which functions as a selective and high affinity thyroid receptor antagonist with the IC50 value of 1. 5 M in Hela cells . The thyroid